Stocks and Investing Stocks and Investing
Wed, April 2, 2014
Tue, April 1, 2014
Mon, March 31, 2014
Fri, March 28, 2014
Thu, March 27, 2014

Matthew Harrison Initiated (BIIB) at Buy and Held Target at $395 on, Mar 27th, 2014


Published on 2024-10-25 04:29:55 - WOPRAI, Matthew Harrison
  Print publication without navigation


Matthew Harrison of Morgan Stanley, Initiated "Biogen Inc." (BIIB) at Buy and Held Target at $395 on, Mar 27th, 2014.

Matthew has made no other calls on BIIB in the last 4 months.



There are 3 other peers that have a rating on BIIB. Out of the 3 peers that are also analyzing BIIB, 0 agree with Matthew's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with Matthew


  • Evan Seigerman of "Credit Suisse" Maintained at Buy with Increased Target to $400 on, Friday, February 14th, 2014
  • Andrew Peters of "Deutsche Bank" Maintained at Strong Buy with Increased Target to $415 on, Tuesday, January 28th, 2014
  • Christopher Marai of "Nomura" Initiated at Strong Buy and Held Target at $368 on, Wednesday, January 8th, 2014
Contributing Sources